Doubts persist over DBT's clinical impact
December 4, 2019 -- Digital breast tomosynthesis (DBT) is developing fast, but some challenges and questions remain in terms of efficiency, efficacy, safety, and quality assurance, as well as the long-term effect on mortality, two leading researchers have noted in an RSNA 2019 presentation.  Discuss
What's AI's clinical role in breast screening?
December 2, 2019 -- The critically important task of showing how artificial intelligence (AI) can enhance patient management surfaced on the first day of RSNA 2019, when the latest clinical evidence of AI's potential contribution in breast screening came under intense scrutiny.  Discuss
Perform biennial screening at 45, say European guidelines
November 27, 2019 -- A new set of guidelines from Europe advise that women should be screened for breast cancer every two to three years between the ages of 45 and 74. The authors suggest that the harm caused by annual screening may well outweigh the benefits.  Discuss
CTPA effectively rules out PE in pregnant women
November 21, 2019 -- A 17-year Swiss study involving pregnant women with suspected pulmonary embolism (PE) has shown that CT pulmonary angiography (CTPA) rarely indicates the disease and more often detects alternative diagnoses. Also, the radiation dose exposure dropped by one-third during the study period.  Discuss
U.K. releases new guidelines on breast screening
November 19, 2019 -- The U.K. Royal College of Radiologists has published detailed guidance on screening and symptomatic breast imaging. Its 27-page report includes advice on the imaging of breast implants and the optimum use of ultrasound.  Discuss
Study of 5M women shows when to start breast screening
November 14, 2019 -- A study of more than 5 million Swedish women released on 14 November in JAMA Oncology provides tangible guidance on when screening should begin for those with a family history of breast cancer. It suggests screening may need to start up to 14 years earlier than national guidelines recommend.  Discuss
German study finds mortality drop after breast screening
November 14, 2019 -- In a large cohort, German researchers observed a reduction in late-stage breast cancer incidence and mortality in women screened for breast cancer, which is most likely due to screening. Also, they noticed overdiagnosis was moderate.  Discuss
Flemish breast screening program needs improvement
November 1, 2019 -- Belgian researchers have found that the Flemish breast cancer screening program's attendance rate could use some improvement, although key performance indicators do hit European Union benchmark targets, according to a study published on 28 October in BMC Cancer.  Discuss
French breast screening: Too much or 20 years ahead?
October 28, 2019 -- France's breast cancer screening strategy is at a crossroads, with urgent decisions pending about the use of digital breast tomosynthesis and digital second reading of exams. Recent deviation from European norms in quality control, however, could affect patient safety, according to leading educator Dr. Luc Ceugnart.  Discuss
MR-HIFU is safe, effective for uterine fibroids
October 25, 2019 -- Dutch researchers have found that MR-guided high-intensity focused ultrasound (MR-HIFU) is a safe therapy for treating uterine fibroids, with a reintervention rate comparable to that of uterine artery embolization. Study results were published on 15 October in the European Journal of Radiology.  Discuss